Jaguar Health (JAGX) Accounts Payables (2014 - 2026)
Jaguar Health's (JAGX) quarterly Accounts Payables came in at $5.0 million in Q1 2026, down 29.47% year-on-year from $7.0 million in Q1 2025, and down 42.93% on a QoQ basis from $8.7 million in Q4 2025.
Jaguar Health (JAGX) Accounts Payables (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Accounts Payables data on file, last reported at $5.0 million in Q1 2026.
- On a quarterly basis, Accounts Payables fell 29.47% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $5.0 million, a 29.47% decrease from a year earlier, with the FY2025 full-year figure at $8.7 million, up 64.32% from the prior year.
- Accounts Payables for Q1 2026 stood at $5.0 million, down from $8.7 million in the prior quarter.
- Over the last five years, Accounts Payables for JAGX reached as high as $8.7 million in Q4 2025 and fell as low as $3.3 million in Q1 2024.
- Historically, Accounts Payables has averaged $5.6 million across 5 years, with a median of $5.3 million in 2024.
- Across the five-year window, Accounts Payables plunged 41.67% in 2024 and jumped 111.69% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $5.8 million in 2022, then retreated by 14.36% to $5.0 million in 2023, then grew by 6.27% to $5.3 million in 2024, then jumped by 64.32% to $8.7 million in 2025, then sank by 42.93% to $5.0 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $5.0 million in Q1 2026, $8.7 million in Q4 2025, and $8.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | 10.38 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 8.64 Mn |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 423.55 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 489.30 Mn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 1.03 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 1.52 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 126.63 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | 80.54 Mn |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 4.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.96 Mn |
| Dec 31, 2025 | 8.69 Mn |
| Sep 30, 2025 | 8.44 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 5.29 Mn |
| Sep 30, 2024 | 4.55 Mn |
| Jun 30, 2024 | 4.09 Mn |
| Mar 31, 2024 | 3.32 Mn |
| Dec 31, 2023 | 4.97 Mn |
| Sep 30, 2023 | 5.13 Mn |
| Jun 30, 2023 | 4.66 Mn |
| Mar 31, 2023 | 5.69 Mn |
| Dec 31, 2022 | 5.81 Mn |
| Sep 30, 2022 | 6.29 Mn |
| Jun 30, 2022 | 5.65 Mn |
| Mar 31, 2022 | 3.71 Mn |
| Dec 31, 2021 | 4.93 Mn |
| Sep 30, 2021 | 3.79 Mn |
| Jun 30, 2021 | 4.92 Mn |